Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
40.64 USD | -1.86% | -2.05% | +14.22% |
08/05 | Oppenheimer Adjusts IDEAYA Biosciences Price Target to $53 From $50, Maintains Outperform Rating | MT |
07/05 | IDEAYA Biosciences Shares Fall After Q1 Loss | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.22% | 3.08B | |
+23.37% | 47.02B | |
+49.96% | 41.86B | |
-0.94% | 41.76B | |
-4.32% | 28.8B | |
+11.29% | 26.05B | |
-20.92% | 19.15B | |
+3.20% | 12.55B | |
-2.67% | 11.82B | |
+30.23% | 12.34B |
- Stock Market
- Equities
- IDYA Stock
- News IDEAYA Biosciences, Inc.
- RBC Raises Price Target on IDEAYA Biosciences to $32 From $30, Maintains Outperform Rating, Speculative Risk Qualifier